期刊文献+

胰腺癌生长抑素受体报告基因表达与其靶向显像的相关性研究 被引量:2

Expression of somatostatin receptor reporter gene and its correlation with targeted imaging in vivo for detection of pancreas carcinoma
原文传递
导出
摘要 目的探讨荷胰腺癌裸鼠模型肿瘤组织生长抑素受体(SSTR)报告基因的mRNA表达水平与99mTc-sandostatin显像对肿瘤的靶向诊断价值及二者的相关性。方法建立荷胰腺癌动物模型,对18只荷胰腺癌裸鼠模型行99mTc-sandostatin显像,勾画感兴趣区,计算瘤体与对侧正常组织的放射性比值(T/NT),用RT-PCR方法检测肿瘤组织SSTR1、SSTR2、SSTR5 mRNA的表达水平,对各SSTR亚型表达水平与T/NT比值进行相关性分析。结果13只荷胰腺癌裸鼠肿瘤清晰显影,瘤组织有较高的局灶性放射性浓聚;6 h T/NT比值达2.53±0.84。5只荷胰腺癌裸鼠显像弱阳性或阴性,6 hT/NT比值为1.04±0.06。肿瘤组织有SSTR1、SSTR2、SSTR5 mRNA表达,SSTR1、SSTR2的表达水平与肿瘤显像阳性裸鼠T/NT比值呈正相关,r分别为0.597(P<0.05)和0.807(P<0.01)。结论荷胰腺癌裸鼠肿瘤组织有SSTR表达,SSTR2尤为显著9。9mTc-sandostatin受体显像对荷胰腺癌动物模型有很好的靶向诊断价值;肿瘤99mTc-sandostatin摄取程度同SSTR1、SSTR2表达水平正相关。 Objective To evaluate the value of ^99mTc-sandostatin scintigraphy in targeted diagnosis of pancreas carcinoma and the correlation with expression of somatostatin receptor (SSTR) reporter gene in tumor tissue. Methods Nude mice bearing human pancreas carcinoma xenograft were established in advance. ^99mTc-sandostatin imaging was performed in 18 nude mice and tumor to normal tissue ratio (T/NT) was calculated, mRNA expression of SSTR1, SSTR2 and SSTR5 in tumor tissue was detected by RT-PCR. Results Out of 18 nude mice, 13 mice showed intense uptake of ^99mTc-sandostatin. Six hours after ^99mTc-sandostatin administration, the T/NT ratio was 2.53 ±0.84. Five mice showed negative findings, and the T/NT ratio was 1.04 ± 0.06. Positive correlations were obtained between the T/NT ratio and the expression of SSTR1 and SSTR2 mRNA , especially SSTR2 (r=0.807, P〈0.01). Conclusion High expression of SSTR1, SSTR2 and SSTR5 mRNA were found in human pancreas tumor xenograft in nude mice, especially SSTR2. There is a significant correlation between the tumor uptake of ^99mTc-sandostatin and SSTR2 mRNA level. This approach may allow SSTR-targeted diagnosis and therapy of human pancreas cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2005年第11期663-666,共4页 Chinese Journal of Oncology
基金 江苏省科技厅社会发展科技指导性计划项目(BS2004507)
关键词 胰腺肿瘤 肿瘤组织生长抑素受体 ^99mTc-sandostatin显像 靶向诊断 Pancreatic neoplasms Somatostatin receptor ^99mTc-sandostatin scintigraphy Targeted diagnosis
  • 相关文献

参考文献8

  • 1虞先浚,蒋永剑,傅德良,倪泉兴.胰腺癌中胸苷磷酸化酶和二氢嘧啶脱氢酶含量及其比值的测定[J].中华肿瘤杂志,2004,26(10):618-620. 被引量:9
  • 2王旭波,宋艳华,时凤娈,王鹏程,王颖,陈卫花.胰腺肿块术中细针穿刺细胞学与快速组织学诊断的对比研究[J].中华肿瘤杂志,2003,25(1):85-87. 被引量:10
  • 3Cwikla JB, Buscombe JR, Mielcarek WA, et al. Comparison of functional imaging and standard CT in evaluation of disease extent in patients with tumours showing neuroendocrine features. Nucl Med Rev Cent East Eur, 2001,4:27-33.
  • 4Zatelli MC, Tagliati F, Taylor JE, et al. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. J Clin Endocrinol Metab,2001,86:2161-2169.
  • 5Gabriel M, Decristoforo C, Donnemiller E, et al. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. J Nucl Med, 2003,44:708-716.
  • 6Rochaix P,Delesque N,Esteve JP, et al. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther,1999,10:995-1008.
  • 7Rogers BE, Chaudhuri TR, Reynolds PN, et al. Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter. Gene Ther,2003,10: 105-114.
  • 8Fisher WE, Doran TA, Muscarella P 2nd, et al. Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst, 1998,90: 322-324.

二级参考文献14

  • 1Ishikawa T,Sekiguchi F,Fukase Y,et al.Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts[].Cancer Research.1998
  • 2Terashima M,Fujiwara H,Takagane A,et al.Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients[].European Journal of Cancer.2002
  • 3Fujiwaki R,Hata K,Nakayama K,et al.Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer[].Journal of Clinical Oncology.2000
  • 4Schuller J,Cassidy J,Dumont E,et al.Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients[].Cancer Chemother.2000
  • 5Hirano Y,Kageyama S,Ushiyama T,et al.Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer[].Cancer Chemother.2003
  • 6Wagman R,Grann A.Adjuvant therapy for pancreatic cancer: current treatment approaches and future challenges[].Surgical Oncology Clinics of North America.2001
  • 7Collie-Duguid ES,Johnston SJ,Boyce L,et al.Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer[].International Journal of Cancer.2001
  • 8Hirano Y,Takayama T,Kageyama S,et al.Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma:relationship between histological parameters and chemosensitivity to 5fluorouracil[].European Urology.2003
  • 9Van Cutsem E,Findlay M,Osterwalder B,et al.Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study[].Journal of Clinical Oncology.2000
  • 10Blum JL,Jones SE,Buzdar AU,et al.Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer[].Journal of Clinical Oncology.1999

共引文献17

同被引文献23

  • 1瞿卫,王自正,王峰,立彦,王书奎.^(99m)Tc-Sandostatin诊断高表达生长抑素受体的胰腺癌的实验研究[J].中国医学影像学杂志,2004,12(5):374-375. 被引量:1
  • 2黎军,何国祥,唐兵.腺病毒介导的AT_2R基因转染对培养大鼠颈动脉内膜增生的影响[J].重庆医学,2005,34(5):723-724. 被引量:3
  • 3Douziech N,Calvo E,Coulombe Z,et al.Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines:a primary role for tyrosine phosphatase SHP-1[J].Endocrinoloy,1999,140:765-777.
  • 4Gillespic J,Poston GJ,Schachter M,et al.Human pancreatic cancer cell lines do not express receptor for somatostatin[J].Br J Cancer,1992,66:483-487.
  • 5Fisher WE,Muscarella P,O′Dorisio TM,et al.Expression of the somatostatin receptors subtype 2 genes predicts response of human pancreatic cancer to octreotide[J].Surgery,1996,120:234-241.
  • 6Reubi JC.Somatostatin receptors in the gastrointestinal tract in health and disease[J].Yale J Biol Med,1992,65(5):493-503.
  • 7Bucail L,Saint Laurent N,Chastre E,et al.Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer[J].Cancer Res,1996,56:1823-1827.
  • 8Gibril F,Jensen RT.Diagnostic users of radiolabelled somatostatin receptor analogues in gastronentero-pancreatic endocrine tumors[J].Dig Liver Dis,2004,36(suppl 1):S106-S120.
  • 9Zalatnai A,Schally AV.Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160[J].Int J Pancreatol.1989,4(2):149-160.
  • 10Evers P,Courtney M,Townsend J,et al.Establishment and characterization of human carcinoid in nude mice and effect of various agents on tumor growth[J].Gantraenterol,1991,101:303-311.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部